20-63693183-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_001283009.2(RTEL1):c.2892T>G(p.Phe964Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,459,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.2892T>G | p.Phe964Leu | missense_variant | 30/35 | ENST00000360203.11 | NP_001269938.1 | |
RTEL1-TNFRSF6B | NR_037882.1 | n.3719T>G | non_coding_transcript_exon_variant | 30/38 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.2892T>G | p.Phe964Leu | missense_variant | 30/35 | 5 | NM_001283009.2 | ENSP00000353332 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249372Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135392
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1459976Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726286
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal recessive 5 Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 23, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Aug 30, 2017 | - - |
RTEL1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2022 | The RTEL1 c.2964T>G variant is predicted to result in the amino acid substitution p.Phe988Leu. This variant was reported in the homozygous state in two siblings with dyskeratosis congenita and one patient with inherited bone marrow failure syndrome (Walne et al 2013. PubMed ID: 23453664; Table S5, Gálvez et al 2021. PubMed ID: 33718801). In the heterozygous state this variant has been reported in two siblings with pulmonary fibrosis (described as p.Phe964Leu, Kannengiesser et al 2015. PubMed ID: 26022962). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating it is rare. This variant is interpreted as likely pathogenic. - |
Dyskeratosis congenita Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 27, 2023 | Variant summary: RTEL1 c.2964T>G (p.Phe988Leu) results in a non-conservative amino acid change located in the Regulator of telomere elongation helicase 1 (IPR030845) of the encoded protein sequence. This variant is also known as c.2892T>G (p.Phe964Leu). Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249372 control chromosomes (gnomAD). c.2964T>G has been reported in the literature in individuals affected with Dyskeratosis Congenita (Hoyeraal Hreidarsson Syndrome) with evidence of cosegregation with disease (Walne_2013). The variant was also found in individuals reported to have features of the disease, including aplastic anemia and pulmonary fibrosis (Arias-Salgado_2019, Galvez_2021, Touzot_2016). Another nucleotide alteration (c.2962T>C) resulting in the same misense change has been found in association with interstitial lung disease (HGMD, Kannengiesser_2015). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 23453664, 26022962, 33718801, 30995915, 29296694). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 14, 2019 | This sequence change replaces phenylalanine with leucine at codon 964 of the RTEL1 protein (p.Phe964Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with Hoyeraal-Hreidarsson (HH) syndrome and familial pulmonary fibrosis in families (PMID: 23453664, 26022962). This variant is also known as p.Phe988Leu in the literature. ClinVar contains an entry for this variant (Variation ID: 553584). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at